✦ LIBER ✦

Hypersensitivity of cortical muscarinic receptors in Parkinson's disease demonstrated by PET

✍ Scribed by M. Asahina; H. Shinotoh; K. Hirayama; T. Suhara; F. Shishido; O. Inoue; Y. Tateno

Book ID: 114784377
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 657 KB
Volume: 91
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.1995.tb00443.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Altered Muscarinic and Nicotinic Recepto

Altered Muscarinic and Nicotinic Receptor Densities in Cortical and Subcortical Brain Regions in Parkinson's Disease

✍ K. W. Lange; F. R. Wells; P. Jenner; C. D. Marsden 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 823 KB

PET demonstrates different behaviour of

PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease

✍ Dr. J. O. Rinne; A. Laihinen; K. Någren; J. Bergman; O. Solin; M. Haaparanta; U. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 609 KB

Striatal dopamine D-1 receptor binding was investigated in vivo with positron emission tomography (PET) in five patients with early Parkinson's disease using ["CI-SCH 23390. All patients had predominantly unilateral symptoms and showed a significant reduction in the accumulation of ["F]-6-F-DOPA in

1.017 Brain acetylcholinesterase changes

1.017 Brain acetylcholinesterase changes in Dementia with Lewy Bodies and Parkinson's disease with Dementia demonstrated by PET

✍ H. Shimada; H. Shigeki; S. Hitoshi; A. Masato; S. Kouichi; T. Noriko; O. Tsuneyo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 68 KB

1.198A Brain acetylcholinesterase change

1.198A Brain acetylcholinesterase changes in Dementia with Lewy Bodies and Parkinson's disease with Dementia demonstrated by PET

✍ H. Shimada; H. Shigeki; S. Hitoshi; A. Masato; S. Kouichi; T. Noriko; O. Tsuneyo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Cortical hypometabolism assessed by a me

Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration—[18F]FDG-PET

✍ Inga Liepelt; Matthias Reimold; Walter Maetzler; Jana Godau; Gerald Reischl; Ale 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB

## Abstract In Parkinson's disease patients with cognitive deterioration, regional cortical hypometabolism has been observed with [^18^F]fluorodeoxyglucose‐positron emission tomography (FDG‐PET). Our aim was to develop a robust method to subsume the overall degree of metabolic deterioration in Park

Absence of residual Hodgkin’s disease de

Absence of residual Hodgkin’s disease demonstrated by PET/CT in a deceased organ donor

✍ John O. Prior; Michel A. Duchosal; Sabine Schmidt; Pierre Turini; Nathalie Pilon 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 197 KB